发明名称 LOXOPROFEN-CONTAINING PHARMACEUTICAL COMPOSITION
摘要 PROBLEM TO BE SOLVED: To provide a stable pharmaceutical composition containing loxoprofen or a salt thereof and lysozyme or a salt thereof.SOLUTION: The invention provides a pharmaceutical composition containing loxoprofen or a salt thereof, lysozyme or a salt thereof, and caffeine (but excluding a tablet (200 mg/tablet) prepared by mixing loxoprofen sodium 90 g, noscapine 48 g, dihydrocodeine phosphate 24 g, ketotifen fumarate 4 g, ambroxol hydrochloride 45 g, phenylpropanolamine 60 g, theophylline 150 g, lysozyme chloride 90 g (titer), anhydrous caffeine 75 g, vitamin Bnitrate 8 g, vitamin B4 g, lactose 350 g, microcrystalline cellulose 320 g, magnesium stearate 16 g, and hydrogenated castor oil 16 g; and a tablet (200 mg/tablet) prepared by mixing loxoprofen sodium 150 g, noscapine 48 g, dihydrocodeine phosphate 24 g, ketotifen fumarate 2 g, ambroxol hydrochloride 45 g, phenylpropanolamine 60 g, theophylline 150 g, lysozyme chloride 90 g (titer), anhydrous caffeine 75 g, vitamin Bnitrate 8 g, vitamin B4 g, lactose 150 g, microcrystalline cellulose 150 g, magnesium stearate 22 g, and hydrogenated castor oil 22 g.)SELECTED DRAWING: None
申请公布号 JP2016056199(A) 申请公布日期 2016.04.21
申请号 JP20160004003 申请日期 2016.01.13
申请人 KOWA COMPANY LTD 发明人 USUI TOSHIKI;HARUHARA MASAAKI;TAKAMIYA MASAYA
分类号 A61K31/192;A61K9/20;A61K31/136;A61K31/137;A61K31/4535;A61K31/4741;A61K31/485;A61K31/51;A61K31/522;A61K31/525;A61K38/46;A61K47/12;A61K47/26;A61K47/38;A61K47/44;A61P29/00 主分类号 A61K31/192
代理机构 代理人
主权项
地址